|
US5086069A
|
|
Anti-thrombotic peptide and pseudopeptide derivatives
|
|
US4946860A
|
|
Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
|
|
US4952562A
|
|
Anti-thrombotic peptides and pseudopeptides
|
|
US4935511A
|
|
Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists
|
|
US4939143A
|
|
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
|
US4924010A
|
|
Benzoxepins as intermediates to 5HT3 antagonists
|
|
US4977162A
|
|
Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments
|
|
US4977246A
|
|
High recovery process for antihemophilic factor
|
|
US4959485A
|
|
Hexahydrodibenzofuran carboxylic acid derivatives
|
|
US4948582A
|
|
Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
|
|
US4944829A
|
|
Apparatus for applying wrappers
|
|
US4900754A
|
|
HMG-COA reductase inhibitors
|
|
US4904691A
|
|
Novel HMG-CoA reductase inhibitors
|
|
US5002771A
|
|
Calcitonin suppository formulations
|
|
US4954494A
|
|
Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heat failure
|
|
US4904692A
|
|
Novel HMG-CoA reductase inhibitors
|
|
US4892884A
|
|
Novel hmg-coa reductase inhibitors
|
|
US4920227A
|
|
Benzobicyclic carboxamide 5-HT3 antagonists
|
|
US4920219A
|
|
Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
|
|
US4933445A
|
|
Heteroazabenzobicyclic carboxamide 5-HT3 antagonists
|
